Neostigmine Methylsulfate

Bloxiverz

Cholinesterase Inhibitor

NADAC/unit N/A

No Shortage 14 Manufacturers 30 ANDAs

Neostigmine Methylsulfate slows cognitive decline in Alzheimer's disease by preserving acetylcholine levels.

Covered Lives

Active Shortages

2026-01-12 Discontinuation of the manufacture of the drug, Fresenius Kabi USA, LLC

Generic Manufacturers

AMNEAL EU LTDAMPHASTAR PHARMACEUTICALS INCAMRING PHARMACEUTICALS INCAVET LIFESCIENCES PRIVATE LTDBE PHARMACEUTICALS AGCAPLIN STERILES LTDDR REDDYS LABORATORIES LTDEXELA PHARMA SCIENCES LLCFRESENIUS KABI USA LLCGLAND PHARMA LTDHIKMA PHARMACEUTICALS USA INCMEITHEAL PHARMACEUTICALS INCPH HEALTH LTDREGCON HOLDINGS LLCSAGENT PHARMACEUTICALS INCUMEDICA LABORATORIES PRIVATE LTD

Explore in the Ecosystem

rxsaver.aiCompare prices for Neostigmine Methylsulfate drfinder.aiFind doctors who prescribe Neostigmine Methylsulfate inhomecare.aiLearn about dementia care rxnews.aiLatest news about Neostigmine Methylsulfate

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.